MESTASTOP SOLUTIONS Trademark
Trademark Overview
On Sunday, January 2, 2022, a trademark application was filed for MESTASTOP SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the MESTASTOP SOLUTIONS trademark a serial number of 97199862. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 17, 2023. This trademark is owned by MESTASTOP SOLUTIONS INC. The MESTASTOP SOLUTIONS trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of various cancers
General Information
| Serial Number | 97199862 |
| Word Mark | MESTASTOP SOLUTIONS |
| Filing Date | Sunday, January 2, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, May 17, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of he artwork shows a cancer cell that is outside the blood vessel. |
| Goods and Services | Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of various cancers |
| Indication of Colors claimed | The color(s) red, blue, and black is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 6, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | MESTASTOP SOLUTIONS INC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Marlton, NJ 08053 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 17, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, May 17, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, May 17, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, October 13, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 13, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, October 13, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, October 6, 2022 | ASSIGNED TO EXAMINER |
| Friday, January 7, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, January 6, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 5, 2022 | NEW APPLICATION ENTERED |
